Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity.

Program in Basic and Clinical Neuroscience, Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio 44106, USA.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.75). 10/1998; 18(18):7394-401.
Source: PubMed

ABSTRACT It has been hypothesized that a deficit in serotonin may be a crucial determinant in the pathophysiology of major depression. Serotonin-1A receptors are located on serotonin cell bodies in the midbrain dorsal raphe (DR) nucleus, and the activation of these receptors inhibits the firing of serotonin neurons and diminishes the release of this neurotransmitter in the prefrontal cortex. Repeated treatment with some antidepressant medications desensitizes serotonin-1A receptors in the rat midbrain. The present study determined whether the binding of [3H]8-hydroxy-2-(di-n-propyl)aminotetralin (8-OH-DPAT), an agonist at serotonin-1A receptors, is altered in the midbrain of suicide victims with major depression. Radiolabeling of the serotonin-1A receptor in the DR varied significantly along the rostral-to-caudal extent of the human midbrain. The binding of [3H]8-OH-DPAT to serotonin-1A receptors was increased significantly in the midbrain DR of suicide victims with major depression as compared with psychiatrically normal control subjects. In suicide victims with major depression, the increase in the binding of [3H]8-OH-DPAT to serotonin-1A receptors was detected in the entire DR and specifically localized to the dorsal and ventrolateral subnuclei. Enhanced radioligand binding of an agonist to inhibitory serotonin-1A autoreceptors in the human DR provides pharmacological evidence to support the hypothesis of diminished activity of serotonin neurons in suicide victims with major depression.

  • The Journal of General Physiology 04/2015; 145(4):257-9. DOI:10.1085/jgp.201511389 · 4.57 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Selective serotonin reuptake inhibitors are the mostly widely used treatment for major depressive disorders and also are prescribed for several anxiety disorders. However, similar to most antidepressants, selective serotonin reuptake inhibitors suffer from two major problems: They only show beneficial effects after 2 to 4 weeks and only about 33% of patients show remission to first-line treatment. Thus, there is a considerable need for development of more effective antidepressants. There is a growing body of evidence supporting critical roles of 5-HT1A and 5-HT4 receptor subtypes in mediating successful depression treatments. In addition, appropriate activation of these receptors may be associated with a faster onset of the therapeutic response. This review will examine the known roles of 5-HT1A and 5-HT4 receptors in mediating both the pathophysiology of depression and anxiety and the treatment of these mood disorders. At the end of the review, the role of these receptors in the regulation of adult hippocampal neurogenesis will also be discussed. Ultimately, we propose that novel antidepressant drugs that selectively target these serotonin receptors could be developed to yield improvements over current treatments for major depressive disorders. © The Author(s) 2014.
    The Neuroscientist 12/2014; DOI:10.1177/1073858414561303 · 7.62 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: La disfunción serotoninérgica está presente en los trastornos del humor y el suicidio. Los autorreceptores somatodrendríticos 5-HT1A del tronco cerebral regulan la descarga de neuronas serotoninérgicas, pero los estudios efectuados sobre la unión a los autorreceptores en el núcleo dorsal del rafe (NDR) en muestras de tejidos obtenidas en víctimas de suicidio deprimidas describen resultados conflictivos. Tratamos de determinar: 1) la distribución anatómica de la unión al receptor 5-HT1A en el NDR de muestras de tejidos obtenidas de víctimas deprimidas de suicidio y de individuos de control sanos, desde un punto de vista psiquiátrico, fallecidos por causas naturales, y 2) si las diferencias de sexo en la unión a 5-HT1A en el NDR contribuyen a las diferencias observadas en las muestras entre víctimas deprimidas de suicidio y los de control. Se analizaron las autorradiografías cuantitativas del receptor de [3H]8-hidroxi-2-(di-n-propil) aminotetralina ([3H]8-OH-DPAT) en las secciones de tejido post mórtem, obtenidas previamente, que contenían el NDR de víctimas de suicidio libres de fármacos/drogas (n=10) y de controles emparejados (n=10). En el NDR íntegro de los suicidas deprimidos, comparado con los controles, se observó una menor unión total al receptor (fmol/mg de tejido×mm3) (p<0,05). Se observaron diferencias de grupo a lo largo de la extensión rostrocaudal del NDR para la unión transversal a 5-HT1A (fmol/mg de tejido) y la unión al receptor (fmol/mg×mm3, p<0,05). Comparado con controles, en el NDR de suicidas deprimidos la unión transversal a 5-HT1A fue mayor rostralmente y menor, caudalmente. Las diferencias entre suicidas deprimidos y controles estuvieron presentes en hombres y mujeres, aunque en estas se detectó una mayor unión que en hombres. La menor unión al autorreceptor en NDR de suicidas deprimidos podría representar una respuesta homeostática a una menor liberación de serotonina, con un incremento de la descarga de las neuronas serotoninérgicas. La mayor unión al autorreceptor en el NDR rostral podría contribuir a una liberación deficiente de serotonina en la corteza prefrontal ventromedial mediante una menor descarga neuronal.
    01/2010; 17(1):12-21. DOI:10.1016/j.psiq.2010.01.003